The n5 - STZ model shows an unaltered basal hyperglycemia, glucose intolerance, raised glycosylated hemoglobin, a strong reduction of the pancreatic insulin stores, decreased basal insulin levels and lack of plasma insulin response to glucose in-vivo. This evidence concerns the gene INS and Hyperglycemia.